Company / Depreciation & Amortization
KIORA PHARMACEUTICALS INC Depreciation & Amortization History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$19.2K
FY2025
5-year range
$19.2K / $51.8K
FY2021-FY2025
Trend
-62.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Depreciation & Amortization has fluctuated over the past 8 years, ranging from $1,257 in FY2016 to $51,798 in FY2024.
Based on SEC 10-K filings.
$19,205 in FY2025 with a 5-year CAGR of -18.0%.
Improved from $33,399 to $19,205 over the past 4 years.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -18.0%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -18.0%, indicating a declining trend.
- In FY2025, depreciation & amortization decreased 62.9% year-over-year.
- Peak depreciation & amortization was recorded in FY2024.
- Lowest depreciation & amortization in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -5.41 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $19.2K | -62.9% |
| FY2024 | $51.8K | +55.1% |
| FY2021 | $33.4K | -35.4% |
| FY2020 | $51.7K | +34.3% |
| FY2019 | $38.5K | +99.5% |
| FY2018 | $19.3K | +272.0% |
| FY2017 | $5.2K | +312.5% |
| FY2016 | $1.3K | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026